U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. Public Health Focus
  4. Warning Letters for Cannabis-Derived Products
  1. Public Health Focus

Warning Letters for Cannabis-Derived Products

This page lists warning letters FDA has issued to firms marketing cannabis-derived products, including cannabidiol (CBD) and delta-8 tetrahydrocannabinol (delta-8 THC) products.

FDA will continue to take action against CBD and other cannabis-derived products to protect the public, in coordination with state regulatory partners, when appropriate. We will remain diligent in monitoring the marketplace and acting within our authorities.

Back to Top